June 10, 2022
Solorio recipient of METAvivor early Career Award grant for novel platform to measure global metabolic activity in breast cancer cells
Cancer treatment screening typically involves use of a synthetic polymer-based substrate, which leads to undesired defects in cell cultures. But researchers at Purdue, including assistant professor Luis Solorio, have developed a biomimetic platform using magnetic actuators for in vitro cell seeding. The setup is compatible with multi-well plates and allows for high throughput, thereby reducing the timeline to develop more targeted cancer therapy. This innovative research was the recipient of a METAvivor Research Program Early Career Award.